Bayer HealthCare Grants4Targets Initiative in: Oncology, Gynecology, Cardiology or Hematology

Objecte

Bayer HealthCare allocates grants for the exploration of attractive, novel drug targets in the fields of:

*Oncology: focus on anti-proliferative, survival signaling, transcription and chromatin modulation, cell cycle regulation, tumor metabolism, hypoxia, immunotherapy and antibody-drug conjugates;
*Gynecology: focus on novel treatment options for endometriosis (incl. adenomyosis uteri/endometriosis interna) and uterine fibroids (uterine leiomyoma);
*Cardiology: focus on novel approaches to the care of chronic and/or acute pulmonary hypertension, atrial fibrillation, heart failure, acute coronary syndrome, ischemic stroke, peripheral arterial occlusive disease, acute lung injury/adult respiratory distress syndrome, cardiorenal syndrome and chronic kidney diseases;
*Hematology: focus on hemophilia, anemia and thrombocytopenia.

Support Grants (€5,000-€10,000) to further advance research on targets that are at a very early stage of discovery; IP rights remain with the applicant.

Focus Grants (€10,000-€125,000) for more mature ideas, e.g. to address specific aspects of a target as a first step towards transferring it to the drug discovery process; IP rights remain with the applicant.

In addition to the financial grants, Bayer may support further work by providing expertise, tools and/or investigations in the areas of: antibodies, small molecule tool compounds, biobank samples, and technologies.

 

Termini IISPV

Declaration of interest: IISPV’s deadline: 08/05/2014 (europa@iispv.cat) Full proposal: IISPV’s deadline: Application 08/25/2014

Termini Oficial

Application deadline: 31/08/14

Estàs interessat?

Omple el següent formulari per rebre més informació: